Incidental esophageal and gastroesophageal junction uptake on ¹8F-FDG PET/CT: when is upper endoscopy warranted?
Year: 2025
Type: article
Study design: Observational Study
Source: Abdominal Radiology
Institutions: Massachusetts General Hospital, Harvard University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Defense, Amgen, Bristol-Myers Squibb, AstraZeneca, Gilead Sciences, Dana-Farber Cancer Institute, Mersana Therapeutics, BeiGene, Daiichi-Sankyo, Astellas Pharma, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer, G1720163979, FIRING UP THE TUMOR MICRO-ENVIRONMENT IN METASTATIC PROSTATE CANCER WITH SYNERGISTIC PSMA-TARGETING RADIOLIGANDS AND STING AGONIST NANO-THERAPIES, Optimized and accessible immuno-PET using lipid nanoparticle-mediated in vivo bioreactor, Enhancing the therapeutic effect of receptor radionuclide therapy in neuroendocrine tumors by somatostatin receptor upregulation, Deep Learning Methods for Improving Gallium 68-Based PET Imaging, G4119534169, G4699294438, G5159251600, G5850682332, G625463624, Molecular Imaging of Fibrosis for Improved Treatment Planning of Pancreatic Ductal Adenocarcinoma, Expanding the therapeutic window of chemoradiation through radiation-responsive nanoparticle drug depots, The impact of upper gastrointestinal dysmotility on aspiration-associated aerodigestive disorders in children
OpenAlex ID: W4415544323